Molekulare Zielstrukturen für die Therapie des Bronchialkarzinoms

Christoph W. M. Reuter, Michael A. Morgan, Lothar Bergmann, Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood. ,vol. 96, pp. 1655- 1669 ,(2000) , 10.1182/BLOOD.V96.5.1655

Jonathan M. Bock, Shyh-Min Huang, Paul M. Harari, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Research. ,vol. 59, pp. 1935- 1940 ,(1999)

Herman D. Suit, Sergey V. Kozin, Daniel J. Hicklin, Yves Boucher, Rakesh K. Jain, Peter Bohlen, Vascular Endothelial Growth Factor Receptor-2-blocking Antibody Potentiates Radiation-induced Long-Term Control of Human Tumor Xenografts Cancer Research. ,vol. 61, pp. 39- 44 ,(2001)

J. Baselga, D. Pfister, M.R. Cooper, R. Cohen, B. Burtness, M. Bos, G. D’Andrea, A. Seidman, L. Norton, K. Gunnett, J. Falcey, V. Anderson, H. Waksal, J. Mendelsohn, Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin Journal of Clinical Oncology. ,vol. 18, pp. 904- 914 ,(2000) , 10.1200/JCO.2000.18.4.904

U. Gatzemeier, G. Groth, V. Hirsh, C. Butts, N. Van Zandwijk, F. Shepherd, R. Rosso, J. Howell, A randomised phase II study of gemcitabine/cisplatin alone and with herceptin in patients with HER2-positive non-small cell lung cancer (nsclc) European Journal of Cancer. ,vol. 37, ,(2001) , 10.1016/S0959-8049(01)80665-1

Deborah A. Thomas, Hagop M. Kantarjian, Current role of thalidomide in cancer treatment Current Opinion in Oncology. ,vol. 12, pp. 564- 573 ,(2000) , 10.1097/00001622-200011000-00009

R K Schmidt-Ullrich, R B Mikkelsen, P Dent, D G Todd, K Valerie, B D Kavanagh, J N Contessa, W K Rorrer, P B Chen, Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. ,vol. 15, pp. 1191- 1197 ,(1997) , 10.1038/SJ.ONC.1201275

Francesc Mitjans, Tim Meyer, Claus Fittschen, Simon Goodman, Alfred Jonczyk, John F. Marshall, German Reyes, Jaume Piulats, In vivo therapy of malignant melanoma by means of antagonists of αv integrins International Journal of Cancer. ,vol. 87, pp. 716- 723 ,(2000) , 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.0.CO;2-R

Michael Baumann, Søren M Bentzen, Wolfgang Doerr, Michael C Joiner, Michele Saunders, Ian F Tannock, Howard D Thames, The translational research chain: is it delivering the goods? International Journal of Radiation Oncology Biology Physics. ,vol. 49, pp. 345- 351 ,(2001) , 10.1016/S0360-3016(00)01483-8

Cordula Petersen, Michael Baumann, Was wissen wir über die Mechanismen des Zeitfaktors in der onkologischen Therapie Strahlentherapie Und Onkologie. ,vol. 176, pp. 443- 447 ,(2000) , 10.1007/PL00002307